Cargando…
B-cell lymphoblastic lymphoma following intravenous BNT162b2 mRNA booster in a BALB/c mouse: A case report
Unprecedented immunization campaigns have been rolled out worldwide in an attempt to contain the ongoing COVID-19 pandemic. Multiple vaccines were brought to the market, among two utilizing novel messenger ribonucleic acid technology. Despite their undisputed success in decreasing COVID-19-associate...
Autores principales: | Eens, Sander, Van Hecke, Manon, Favere, Kasper, Tousseyn, Thomas, Guns, Pieter-Jan, Roskams, Tania, Heidbuchel, Hein |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10183601/ https://www.ncbi.nlm.nih.gov/pubmed/37197431 http://dx.doi.org/10.3389/fonc.2023.1158124 |
Ejemplares similares
-
Addendum: B-cell lymphoblastic lymphoma following intravenous BNT162b2 mRNA booster in a BALB/c mouse: a case report
por: Eens, Sander, et al.
Publicado: (2023) -
Effect of BNT162b2 mRNA booster vaccination on VO(2)
(max) in recreational athletes: A prospective cohort study
por: Miljoen, Hielko, et al.
Publicado: (2022) -
Rapid Progression of Angioimmunoblastic T Cell Lymphoma Following BNT162b2 mRNA Vaccine Booster Shot: A Case Report
por: Goldman, Serge, et al.
Publicado: (2021) -
BNT162b2 Vaccine Booster and Mortality Due to Covid-19
por: Arbel, Ronen, et al.
Publicado: (2021) -
Frosted branch angiitis after booster vaccination with BNT162b2
por: Haas, A.-M., et al.
Publicado: (2023)